Product review · Updated September 30, 2026
Peter Thomas Roth Peptide Skinjection serum review: separate the serum from the solution studies
The Amplified Wrinkle-Fix Serum has a non-copper peptide list and three distinct study summaries; Skinjection is not injection equivalence.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Peptide Skinjection Amplified Wrinkle-Fix Serum uses a name that makes the relationship to injections an obvious reading question. The exact official record is a topical serum, SKU1501069. Its ingredient list and the footnotes beneath its claims provide a more specific account than the marketing name alone.
No copper ingredient is named in the reviewed full declaration. This is an other-peptide comparator whose page combines a consumer study, a clinically measured study and a separate ingredient-solution study after neurotoxin injections. Those subjects remain distinct throughout the review, without a procedure recommendation or an inferred promise that this serum replaces injections.
In this article
Start with the exact amplified serum
The manufacturer’s product page identifies Peptide Skinjection Amplified Wrinkle-Fix Serum, SKU1501069, and a 30 ml presentation. Serum is the product wording in this account. The brand’s Clinical Skin Care identity and non-invasive description remain promotional wording rather than proof of a clinically equivalent procedure or an independently observed result.
The exact amplified name also prevents related products from being merged into this record. The Paula’s Choice review is another reading topic for a specifically named peptide preparation. Following the link does not create a performance comparison, and no bottle was used to test either product for this publication.
The full list describes more than a peptide complex
The complete declaration names Acetyl Hexapeptide-8 and Pentapeptide-18, together with additional peptides. It also includes ingredients such as Dimethicone, Squalane and glycerin. No copper name appears in that full block. The review therefore classifies this serum as Other peptides, with the conclusion tied to the captured official list.
The whole preparation is a relevant subject of the review, rather than an invisible carrier around a highlighted active. The moisturizer-role article offers context for reading multi-ingredient topical formats. It does not establish that this serum is a cream, predict personal texture preferences or isolate the effect of one peptide from the rest of the formula.
Complex percentages are not pure-peptide assay results
The brand’s description advertises a 19% Peptide Complex and 10% Argirelox, alongside named Matrixyl and Argireline solution percentages. Those are marketed complex and solution descriptions. The reviewed record does not provide an independent assay showing the pure amount of every individual peptide in the final serum or a method for reconciling all the displayed numbers.
Adding the headline figures or treating each solution percentage as pure peptide would supply a specification the source has not established. Neither the serum’s SKU nor its 30 ml presentation identifies those figures as pure-peptide measurements; identity and analytical specification need different supporting records. The percentage guide develops that distinction. This article preserves the company’s quantitative language as product marketing, without calculating potency, delivery or greater benefit from the size of a printed percentage.
The consumer and measured studies are separate accounts
The results footnotes describe a six-week consumer-perception study involving 28 women aged 37–64, with 93% agreeing that no new lines had formed. Another footnote describes a four-week clinically measured study involving 53 women in that age range. The headline’s early-result language must be read beside the latter study’s stated duration.
Agreement in a perception survey is not the same endpoint as a clinically measured result. The populations cannot be merged into one larger study, and no full methods, control or participant-level results were reviewed. These remain manufacturer summaries, with no independent confirmation here of the exact serum’s effect or a promised response in mature facial skin.
The injection-related footnote concerns an ingredient solution
A different footnote describes 22 women, averaging 51 years of age, who received a neurotoxin treatment followed by a 10% Argirelox peptide solution. The reported follow-up extended over six months. That is an ingredient-solution adjunct setting, not automatically a trial of the current Amplified Wrinkle-Fix Serum as a replacement for an injectable procedure.
The manufacturer connects this evidence with prolonging the need for another treatment. This review does not adopt that as a verified serum outcome or a procedure timetable. The formulation, prior intervention and study subject matter are essential qualifications; a benefit attributed to the ingredient solution cannot be silently transferred to the full serum or an individual reader.
Skinjection is a name, not a clinical equivalence finding
The product record places the Skinjection name, a non-invasive description and injection-related claims together. The distinction between its serum studies and the solution adjunct study limits what that wording can establish. Nothing examined here demonstrates that using this particular serum is clinically interchangeable with a neurotoxin treatment.
The DERMA E review provides another topic for reading a brand’s clinical-results language. It is a documentary connection, not a shared trial or comparison of benefits. This article supplies no treatment choice, injection avoidance plan or personal clearance; the named serum is reviewed as the topical preparation its official record identifies.
The strongest conclusion preserves all three study subjects
The page supports a named other-peptide serum and a detailed ingredient block. It also offers separate consumer, measured and ingredient-solution summaries. Without complete reports or a batch assay, those records cannot establish independently verified concentration, universal efficacy or injection equivalence. Keeping their distinct sample sizes and durations makes the review more accurate, not less useful.
The cream-and-serum comparison provides context for this broader-peptide comparator. No copper identity is invented from a clinical brand name, and no result is borrowed from another Skinjection preparation. The finished serum remains the review’s subject, with promotional benefits attributed and the underlying evidence boundaries visible.
Sources behind this reading
- Peter Thomas Roth: Peptide Skinjection Amplified Wrinkle-Fix Serum ↗Exact serum SKU, complete non-copper list, solution-complex claims and three distinct study summaries · Checked September 30, 2026